Browse 24910 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
September 7th, 2026 |
NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2027 |
NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional) |
National Institutes of Health |
March 29th, 2024 |
Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed) |
National Institutes of Health |
January 9th, 2024 |
Single Source: AIDS and Cancer Specimen Resource (ACSR; UM1 Clinical Trials Not Allowed) |
National Institutes of Health |
August 18th, 2026 |
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
August 18th, 2024 |
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2027 |
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
January 29th, 2024 |
BRAIN Initiative Connectivity across Scales Data Coordinating Center (BRAIN CONNECTS DCC) (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
October 14th, 2026 |
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) |
National Institutes of Health |
October 14th, 2026 |
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
March 1st, 2024 |
Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional) |
National Institutes of Health |
March 1st, 2024 |
Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional) |
National Institutes of Health |
November 17th, 2026 |
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
February 22nd, 2024 |
IND-enabling Studies for Platform Clinical Trials of Genome Editing in Multiple Diseases (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
July 1st, 2024 |
Short Courses in Social Determinants of Health for Research Education in Nursing Research (R25 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
November 15th, 2024 |
Advancing Technologies to Improve Delivery of Pharmacological, Gene Editing, and other Cargoes for HIV and SUD Mechanistic or Therapeutic Research (R01 Clinical Trial Optional) |
National Institutes of Health |
February 28th, 2024 |
Psychedelics Treatment Research in Substance Use Disorder (UG3/UH3 Clinical Trials Optional) |
National Institutes of Health |
November 17th, 2023 |
USAID/Cambodia Community Mobilization Initiatives to End Tuberculosis 2 (COMMIT 2) |
Cambodia USAID Phnom Penh |
November 16th, 2026 |
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) |
National Institutes of Health |
November 18th, 2026 |
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) |
National Institutes of Health |
|
November 18th, 2026 |
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) |
National Institutes of Health |
November 15th, 2024 |
Effect of HIV and Substance Use Comorbidity on the Placenta and Maternal Outcomes (R01 Clinical Trial Optional) |
National Institutes of Health |
November 10th, 2023 |
USAID/Kenya and East Africa Social Behavior Change Activity |
Kenya USAID Nairobi |
December 11th, 2023 |
Sustaining Impact for Youth Activity |
Haiti USAID Port Au Prince |
February 21st, 2024 |
Building an Effective, Robust and Sustainable Integrated Sample Transportation System in Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
December 28th, 2023 |
Fortifying OVC services, Empowering adolescents, and youth, and Leveraging and Incorporating community feedback in Zambezia (FELIZ) Activity |
Mozambique USAID Maputo |
April 16th, 2024 |
Resource Center for Cannabis and Cannabinoid Research (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
February 1st, 2024 |
Fiscal Year (FY) 2024 AmeriCorps Seniors Senior Companion Program (SCP) Replacement and Expansion Opportunity |
AmeriCorps |
February 1st, 2024 |
Fiscal Year (FY 2024 AmeriCorps Seniors Foster Grandparents (FGP) Replacement and Expansion Opportunity Program |
AmeriCorps |
March 14th, 2024 |
Tools for decentralized clinical trials for substance use disorder (R43/R44 Clinical Trials Optional) |
National Institutes of Health |
March 14th, 2024 |
Tools for Decentralized Clinical Trials for Substance Use Disorder (R41/R42 Clinical Trials Optional) |
National Institutes of Health |
May 7th, 2024 |
Advancing Hearing and Balance Research Using Auditory and Vestibular Organoids (R01-Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2024 |
Advancing Hearing and Balance Research Using Auditory and Vestibular Organoids (R21-Clinical Trial Not Allowed) |
National Institutes of Health |
March 13th, 2024 |
Engineering and Preclinical Development of Biological Products that Eliminate HIV-infected Cells (UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
March 13th, 2024 |
Long-Acting Drug Delivery Systems for ART Optimization in Children Living with HIV-1 II (LADDS II) (R61/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
January 26th, 2024 |
Development of Candidate Radiation/Nuclear Medical Countermeasures (MCMs) (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
February 28th, 2024 |
Single Source for continuation of the Human Pancreas Analysis Program for Type-2 Diabetes (HPAP-T2D) (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
April 15th, 2024 |
Early Detection of Certain Medical Conditions Related to Environmental Health Hazards |
Centers for Disease Control ATSDR |
April 15th, 2024 |
State Biomonitoring Programs: Assessing disproportionate exposure to environmental chemicals among communities |
Centers for Disease Control NCEH |
March 8th, 2024 |
Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Pathogens in China |
Centers for Disease Control and Prevention ERA |